Document is current

Article History

Received: 15 October 2025

Revised: 1 February 2026

Accepted: 3 February 2026

First Online: 18 February 2026

Declarations

:

: Paul M. Friedman received grants from Acclaro Corp and Bausch as an investigator. He received a speaker honorarium for Solta Medical and Candela. He serves on the Advisory Board for Allergan, Solta Medical, Candela, Acclaro Corp, and R2 Technologies. He has stock options in Acclaro Corp. Emily L. Guo received speaker honorarium for Acclaro Corp and Solta Medical. Rasika Reddy, Mary Dick, and Ritu Swali have no relevant financial or non-financial conflicts of interest to declare.

: The patient included in this manuscript provided written patient consent to include their medical information and photographs for publication in print and online with the understanding that this information may be publicly available. This manuscript is a case report and as such, did not require review or exemption by an institutional ethics committee under our institutional policies. No formal ethics committee approval was sought or granted. The case was conducted in accordance with the principles outlined in the Declaration of Helsinki and its subsequent amendments, and informed consent for publication was obtained from the patient. This study does not include any animal models. This study does not involve a clinical trial. Paul M. Friedman, MD, is on the medical advisory board for Acclaro Medical. No other listed authors have any conflicts of interest to disclose.